<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32103448</PMID><DateCompleted><Year>2021</Year><Month>07</Month><Day>01</Day></DateCompleted><DateRevised><Year>2023</Year><Month>12</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1995-820X</ISSN><JournalIssue CitedMedium="Internet"><Volume>35</Volume><Issue>4</Issue><PubDate><Year>2020</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Virologica Sinica</Title><ISOAbbreviation>Virol Sin</ISOAbbreviation></Journal><ArticleTitle>Structure of the HRV-C 3C-Rupintrivir Complex Provides New Insights for Inhibitor Design.</ArticleTitle><Pagination><StartPage>445</StartPage><EndPage>454</EndPage><MedlinePgn>445-454</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s12250-020-00196-4</ELocationID><Abstract><AbstractText>Human rhinoviruses (HRVs) are the predominant infectious agents for the common cold worldwide. The HRV-C species cause severe illnesses in children and are closely related to acute exacerbations of asthma. 3C protease, a highly conserved enzyme, cleaves the viral polyprotein during replication and assists the virus in escaping the host immune system. These key roles make 3C protease an important drug target. A few structures of 3Cs complexed with an irreversible inhibitor rupintrivir have been determined. These structures shed light on the determinants of drug specificity. Here we describe the structures of HRV-C15 3C in free and inhibitor-bound forms. The volume-decreased S1' subsite and half-closed S2 subsite, which were thought to be unique features of enterovirus A 3C proteases, appear in the HRV-C 3C protease. Rupintrivir assumes an "intermediate" conformation in the complex, which might open up additional avenues for the design of potent antiviral inhibitors. Analysis of the features of the three-dimensional structures and the amino acid sequences of 3C proteases suggest new applications for existing drugs.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yuan</LastName><ForeName>Shuai</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>CAS Key Laboratory of Infection and Immunity, CAS Center for Excellence in Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing, 100101, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Molecular Biophysics and Biochemistry, Yale University, New Haven, CT, 06511, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fan</LastName><ForeName>Kaiyue</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>CAS Key Laboratory of Infection and Immunity, CAS Center for Excellence in Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing, 100101, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Beijing Forestry University, No. 35 Tsinghua East Road, Haidian District, Beijing, 100083, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Zhonghao</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Key Laboratory for Space Bioscience and Space Biotechnology, School of Life Sciences, Northwestern Polytechnical University, Xi'an, 710072, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Medical Research, Northwestern Polytechnical University, Xi'an, 710072, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Yao</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>CAS Key Laboratory of Infection and Immunity, CAS Center for Excellence in Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing, 100101, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hou</LastName><ForeName>Hai</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0003-4199-354X</Identifier><AffiliationInfo><Affiliation>Key Laboratory for Space Bioscience and Space Biotechnology, School of Life Sciences, Northwestern Polytechnical University, Xi'an, 710072, China. houhai@nwpu.edu.cn.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Medical Research, Northwestern Polytechnical University, Xi'an, 710072, China. houhai@nwpu.edu.cn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhu</LastName><ForeName>Ling</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0002-6174-296X</Identifier><AffiliationInfo><Affiliation>CAS Key Laboratory of Infection and Immunity, CAS Center for Excellence in Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing, 100101, China. lingzhu@ibp.ac.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>02</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Virol Sin</MedlineTA><NlmUniqueID>101514185</NlmUniqueID><ISSNLinking>1995-820X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007555">Isoxazoles</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011760">Pyrrolidinones</NameOfSubstance></Chemical><Chemical><RegistryNumber>47E5O17Y3R</RegistryNumber><NameOfSubstance UI="D010649">Phenylalanine</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.22.28</RegistryNumber><NameOfSubstance UI="D000086042">3C Viral Proteases</NameOfSubstance></Chemical><Chemical><RegistryNumber>HG18B9YRS7</RegistryNumber><NameOfSubstance UI="D014633">Valine</NameOfSubstance></Chemical><Chemical><RegistryNumber>RGE5K1Q5QW</RegistryNumber><NameOfSubstance UI="C118874">rupintrivir</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000086042" MajorTopicYN="N">3C Viral Proteases</DescriptorName><QualifierName UI="Q000037" MajorTopicYN="Y">antagonists &amp; inhibitors</QualifierName><QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018360" MajorTopicYN="N">Crystallography, X-Ray</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015195" MajorTopicYN="Y">Drug Design</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D029821" MajorTopicYN="N">Enterovirus A, Human</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000201" MajorTopicYN="N">enzymology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007555" MajorTopicYN="N">Isoxazoles</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008958" MajorTopicYN="N">Models, Molecular</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010649" MajorTopicYN="N">Phenylalanine</DescriptorName><QualifierName UI="Q000031" MajorTopicYN="Y">analogs &amp; derivatives</QualifierName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017434" MajorTopicYN="N">Protein Structure, Tertiary</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011760" MajorTopicYN="N">Pyrrolidinones</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017422" MajorTopicYN="N">Sequence Analysis, DNA</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014633" MajorTopicYN="N">Valine</DescriptorName><QualifierName UI="Q000031" MajorTopicYN="Y">analogs &amp; derivatives</QualifierName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">3C protease</Keyword><Keyword MajorTopicYN="N">Human rhinoviruses (HRVs)</Keyword><Keyword MajorTopicYN="N">Inhibitors</Keyword><Keyword MajorTopicYN="N">Rupintrivir (AG7088)</Keyword><Keyword MajorTopicYN="N">Three-dimensional structures</Keyword></KeywordList><CoiStatement>The authors declare that they have no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>8</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>12</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>2</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>7</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>2</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>2</Month><Day>26</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32103448</ArticleId><ArticleId IdType="pmc">PMC7462945</ArticleId><ArticleId IdType="doi">10.1007/s12250-020-00196-4</ArticleId><ArticleId IdType="pii">10.1007/s12250-020-00196-4</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Adams PD, Afonine PV, Bunkoczi G, Chen VB, Davis IW, Echols N, Headd JJ, Hung LW, Kapral GJ, Grosse-Kunstleve RW, McCoy AJ, Moriarty NW, Oeffner R, Read RJ, Richardson DC, Richardson JS, Terwilliger TC, Zwart PH. PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr Sect D-Biol Crystallogr. 2010;66:213&#x2013;221. doi: 10.1107/S0907444909052925.</Citation><ArticleIdList><ArticleId IdType="doi">10.1107/S0907444909052925</ArticleId><ArticleId IdType="pmc">PMC2815670</ArticleId><ArticleId IdType="pubmed">20124702</ArticleId></ArticleIdList></Reference><Reference><Citation>Anand K, Palm GJ, Mesters JR, Siddell SG, Ziebuhr J, Hilgenfeld R. Structure of coronavirus main proteinase reveals combination of a chymotrypsin fold with an extra alpha-helical domain. EMBO J. 2002;21:3213&#x2013;3224. doi: 10.1093/emboj/cdf327.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/emboj/cdf327</ArticleId><ArticleId IdType="pmc">PMC126080</ArticleId><ArticleId IdType="pubmed">12093723</ArticleId></ArticleIdList></Reference><Reference><Citation>Arden KE, McErlean P, Nissen MD, Sloots TP, Mackay IM. Frequent detection of human rhinoviruses, paramyxoviruses, coronaviruses, and bocavirus during acute respiratory tract infections. J Med Virol. 2006;78:1232&#x2013;1240. doi: 10.1002/jmv.20689.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.20689</ArticleId><ArticleId IdType="pmc">PMC7167201</ArticleId><ArticleId IdType="pubmed">16847968</ArticleId></ArticleIdList></Reference><Reference><Citation>Arruda E, Pitkaranta A, Witek TJ, Jr, Doyle CA, Hayden FG. Frequency and natural history of rhinovirus infections in adults during autumn. J Clin Microbiol. 1997;35:2864&#x2013;2868. doi: 10.1128/JCM.35.11.2864-2868.1997.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.35.11.2864-2868.1997</ArticleId><ArticleId IdType="pmc">PMC230076</ArticleId><ArticleId IdType="pubmed">9350748</ArticleId></ArticleIdList></Reference><Reference><Citation>Barral PM, Sarkar D, Fisher PB, Racaniello VR. RIG-I is cleaved during picornavirus infection. Virology. 2009;391:171&#x2013;176. doi: 10.1016/j.virol.2009.06.045.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2009.06.045</ArticleId><ArticleId IdType="pmc">PMC2743091</ArticleId><ArticleId IdType="pubmed">19628239</ArticleId></ArticleIdList></Reference><Reference><Citation>Baxter A, Chambers M, Edfeldt F, Edman K, Freeman A, Johansson C, King S, Morley A, Petersen J, Rawlins P, Spadola L, Thong B, Van de Poel H, Williams N. Non-covalent inhibitors of rhinovirus 3C protease. Bioorg Med Chem Lett. 2011;21:777&#x2013;780. doi: 10.1016/j.bmcl.2010.11.110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bmcl.2010.11.110</ArticleId><ArticleId IdType="pubmed">21183345</ArticleId></ArticleIdList></Reference><Reference><Citation>Binford SL, Maldonado F, Brothers MA, Weady PT, Zalman LS, Meador JW, Matthews DA, Patick AK. Conservation of amino acids in human rhinovirus 3C protease correlates with broad-spectrum antiviral activity of rupintrivir, a novel human rhinovirus 3C protease inhibitor. Antimicrob Agents Chemother. 2005;49:619&#x2013;626. doi: 10.1128/AAC.49.2.619-626.2005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/AAC.49.2.619-626.2005</ArticleId><ArticleId IdType="pmc">PMC547258</ArticleId><ArticleId IdType="pubmed">15673742</ArticleId></ArticleIdList></Reference><Reference><Citation>Bizzintino J, Lee WM, Laing IA, Vang F, Pappas T, Zhang G, Martin AC, Khoo SK, Cox DW, Geelhoed GC, McMinne PC, Goldblatt J, Gern JE, Le Soue PN. Association between human rhinovirus C and severity of acute asthma in children. Eur Respir J. 2011;37:1037&#x2013;1042. doi: 10.1183/09031936.00092410.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/09031936.00092410</ArticleId><ArticleId IdType="pmc">PMC3024467</ArticleId><ArticleId IdType="pubmed">20693244</ArticleId></ArticleIdList></Reference><Reference><Citation>Bochkov YA, Watters K, Ashraf S, Griggs TF, Devries MK, Jackson DJ, Palmenberg AC, Gern JE. Cadherin-related family member 3, a childhood asthma susceptibility gene product, mediates rhinovirus C binding and replication. Proc Natl Acad Sci USA. 2015;112:5485&#x2013;5490. doi: 10.1073/pnas.1421178112.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1421178112</ArticleId><ArticleId IdType="pmc">PMC4418890</ArticleId><ArticleId IdType="pubmed">25848009</ArticleId></ArticleIdList></Reference><Reference><Citation>Croft SN, Walker EJ, Ghildyal R. Human Rhinovirus 3C protease cleaves RIPK1, concurrent with caspase 8 activation. Sci Rep. 2018;8:1569. doi: 10.1038/s41598-018-19839-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-19839-4</ArticleId><ArticleId IdType="pmc">PMC5785518</ArticleId><ArticleId IdType="pubmed">29371673</ArticleId></ArticleIdList></Reference><Reference><Citation>DeLano WL. Use of PYMOL as a communications tool for molecular science. Abstracts P Am Chem Soc. 2004;228:U313&#x2013;U314.</Citation></Reference><Reference><Citation>Dereeper A, Guignon V, Blanc G, Audic S, Buffet S, Chevenet F, Dufayard JF, Guindon S, Lefort V, Lescot M, Claverie JM, Gascuel O. Phylogeny.fr: robust phylogenetic analysis for the non-specialist. Nucleic Acids Res. 2008;36:W465&#x2013;469. doi: 10.1093/nar/gkn180.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkn180</ArticleId><ArticleId IdType="pmc">PMC2447785</ArticleId><ArticleId IdType="pubmed">18424797</ArticleId></ArticleIdList></Reference><Reference><Citation>Dereeper A, Audic S, Claverie JM, Blanc G. BLAST-EXPLORER helps you building datasets for phylogenetic analysis. BMC Evol Biol. 2010;10:8. doi: 10.1186/1471-2148-10-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2148-10-8</ArticleId><ArticleId IdType="pmc">PMC2821324</ArticleId><ArticleId IdType="pubmed">20067610</ArticleId></ArticleIdList></Reference><Reference><Citation>Dragovich PS, Webber SE, Babine RE, Fuhrman SA, Patick AK, Matthews DA, Reich SH, Marakovits JT, Prins TJ, Zhou R, Tikhe J, Littlefield ES, Bleckman TM, Wallace MB, Little TL, Ford CE, Meador JW, Ferre RA, Brown EL, Binford SL, DeLisle DM, Worland ST. Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 2. Peptide structure-activity studies. J Med Chem. 1998;41:2819&#x2013;2834. doi: 10.1021/jm9800696.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/jm9800696</ArticleId><ArticleId IdType="pubmed">9667971</ArticleId></ArticleIdList></Reference><Reference><Citation>Dragovich PS, Prins TJ, Zhou R, Fuhrman SA, Patick AK, Matthews DA, Ford CE, Meador JW, Ferre RA, Worland ST. Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 3. Structure - Activity studies of ketomethylene-containing peptidomimetics. J Med Chem. 1999;42:1203&#x2013;1212. doi: 10.1021/jm980537b.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/jm980537b</ArticleId><ArticleId IdType="pubmed">10197964</ArticleId></ArticleIdList></Reference><Reference><Citation>Dragovich PS, Prins TJ, Zhou R, Webber SE, Marakovits JT, Fuhrman SA, Patick AK, Matthews DA, Lee CA, Ford CE, Burke BJ, Rejto PA, Hendrickson TF, Tuntland T, Brown EL, Meador JW, Ferre RA, Harr JEV, Kosa MB, Worland ST. Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 4. Incorporation of P-1 lactam moieties as L-glutamine replacements. J Med Chem. 1999;42:1213&#x2013;1224. doi: 10.1021/jm9805384.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/jm9805384</ArticleId><ArticleId IdType="pubmed">10197965</ArticleId></ArticleIdList></Reference><Reference><Citation>Emsley P, Cowtan K. Coot: model-building tools for molecular graphics. Acta Crystallogr Sect D-Biol Crystallogr. 2004;60:2126&#x2013;2132. doi: 10.1107/S0907444904019158.</Citation><ArticleIdList><ArticleId IdType="doi">10.1107/S0907444904019158</ArticleId><ArticleId IdType="pubmed">15572765</ArticleId></ArticleIdList></Reference><Reference><Citation>Greve JM, Davis G, Meyer AM, Forte CP, Yost SC, Marior CW, Kamarck ME, Mcclelland A. The major human rhinovirus receptor Is Icam-1. Cell. 1989;56:839&#x2013;847. doi: 10.1016/0092-8674(89)90688-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0092-8674(89)90688-0</ArticleId><ArticleId IdType="pubmed">2538243</ArticleId></ArticleIdList></Reference><Reference><Citation>Hao W, Bernard K, Patel N, Ulbrandt N, Feng H, Svabek C, Wilson S, Stracener C, Wang K, Suzich J, Blair W, Zhu Q. Infection and propagation of human rhinovirus C in human airway epithelial cells. J Virol. 2012;86:13524&#x2013;13532. doi: 10.1128/JVI.02094-12.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02094-12</ArticleId><ArticleId IdType="pmc">PMC3503113</ArticleId><ArticleId IdType="pubmed">23035218</ArticleId></ArticleIdList></Reference><Reference><Citation>Hofer F, Gruenberger M, Kowalski H, Machat H, Huettinger M, Kuechler E, Blaas D. Members of the low-density-lipoprotein receptor family mediate cell entry of a minor-group common cold virus. Proc Natl Acad Sci USA. 1994;91:1839&#x2013;1842. doi: 10.1073/pnas.91.5.1839.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.91.5.1839</ArticleId><ArticleId IdType="pmc">PMC43259</ArticleId><ArticleId IdType="pubmed">8127891</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnston SL, Pattemore PK, Sanderson G, Smith S, Lampe F, Josephs L, Symington P, Otoole S, Myint SH, Tyrrell DAJ, Holgate ST. Community study of role of viral-infections in exacerbations of asthma in 9&#x2013;11 year-old children. BMJ. 1995;310:1225&#x2013;1229. doi: 10.1136/bmj.310.6989.1225.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.310.6989.1225</ArticleId><ArticleId IdType="pmc">PMC2549614</ArticleId><ArticleId IdType="pubmed">7767192</ArticleId></ArticleIdList></Reference><Reference><Citation>Lamson D, Renwick N, Kapoor V, Liu Z, Palacios G, Ju J, Dean A, George KS, Briese T, Lipkin WI. MassTag polymerase-chain-reaction detection of respiratory pathogens, including a new rhinovirus genotype, that caused influenza-like illness in New York State during 2004&#x2013;2005. J Infect Dis. 2006;194:1398&#x2013;1402. doi: 10.1086/508551.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/508551</ArticleId><ArticleId IdType="pmc">PMC7110122</ArticleId><ArticleId IdType="pubmed">17054069</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee CC, Kuo CJ, Ko TP, Hsu MF, Tsui YC, Chang SC, Yang S, Chen SJ, Chen HC, Hsu MC, Shih SR, Liang PH, Wang AH. Structural basis of inhibition specificities of 3C and 3C-like proteases by zinc-coordinating and peptidomimetic compounds. J Biol Chem. 2009;284:7646&#x2013;7655. doi: 10.1074/jbc.M807947200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M807947200</ArticleId><ArticleId IdType="pmc">PMC2658058</ArticleId><ArticleId IdType="pubmed">19144641</ArticleId></ArticleIdList></Reference><Reference><Citation>Lotzerich M, Roulin PS, Boucke K, Witte R, Georgiev O, Greber UF. Rhinovirus 3C protease suppresses apoptosis and triggers caspase-independent cell death. Cell Death Dis. 2018;9:272. doi: 10.1038/s41419-018-0306-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41419-018-0306-6</ArticleId><ArticleId IdType="pmc">PMC5833640</ArticleId><ArticleId IdType="pubmed">29449668</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu GW, Qi JX, Chen ZJ, Xu X, Gao F, Lin DZ, Qian WK, Liu H, Jiang HL, Yan JH, Gao GF. Enterovirus 71 and coxsackievirus A16 3C proteases: binding to rupintrivir and their substrates and anti-hand, foot, and mouth disease virus drug design. J Virol. 2011;85:10319&#x2013;10331. doi: 10.1128/JVI.00787-11.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00787-11</ArticleId><ArticleId IdType="pmc">PMC3196414</ArticleId><ArticleId IdType="pubmed">21795339</ArticleId></ArticleIdList></Reference><Reference><Citation>Matthews DA, Dragovich PS, Webber SE, Fuhrman SA, Patick AK, Zalman LS, Hendrickson TF, Love RA, Prins TJ, Marakovits JT, Zhou R, Tikhe J, Ford CE, Meador JW, Ferre RA, Brown EL, Binford SL, Brothers MA, DeLisle DM, Worland ST. Structure-assisted design of mechanism-based irreversible inhibitors of human rhinovirus 3C protease with potent antiviral activity against multiple rhinovirus serotypes. Proc Natl Acad Sci USA. 1999;96:11000&#x2013;11007. doi: 10.1073/pnas.96.20.11000.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.96.20.11000</ArticleId><ArticleId IdType="pmc">PMC34232</ArticleId><ArticleId IdType="pubmed">10500114</ArticleId></ArticleIdList></Reference><Reference><Citation>Mccoy AJ, Grosse-Kunstleve RW, Adams PD, Winn MD, Storoni LC, Read RJ. Phaser crystallographic software. J Appl Crystallogr. 2007;40:658&#x2013;674.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2483472</ArticleId><ArticleId IdType="pubmed">19461840</ArticleId></ArticleIdList></Reference><Reference><Citation>Mello C, Aguayo E, Rodriguez M, Lee G, Jordan R, Cihlar T, Birkus G. Multiple classes of antiviral agents exhibit In Vitro activity against human rhinovirus type C. Antimicrob Agents Chemother. 2014;58:1546&#x2013;1555. doi: 10.1128/AAC.01746-13.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/AAC.01746-13</ArticleId><ArticleId IdType="pmc">PMC3957863</ArticleId><ArticleId IdType="pubmed">24366736</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller EK, Khuri-Bulos N, Williams JV, Shehabi AA, Faouri S, Al Jundi I, Chen QX, Heil L, Mohamed Y, Morin LL, Ali A, Halasa NB. Human rhinovirus C associated with wheezing in hospitalised children in the Middle East. J Clin Virol. 2009;46:85&#x2013;89. doi: 10.1016/j.jcv.2009.06.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2009.06.007</ArticleId><ArticleId IdType="pmc">PMC2759319</ArticleId><ArticleId IdType="pubmed">19581125</ArticleId></ArticleIdList></Reference><Reference><Citation>Mosimann SC, Cherney MM, Sia S, Plotch S, James MN. Refined X-ray crystallographic structure of the poliovirus 3C gene product. J Mol Biol. 1997;273:1032&#x2013;1047. doi: 10.1006/jmbi.1997.1306.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/jmbi.1997.1306</ArticleId><ArticleId IdType="pubmed">9367789</ArticleId></ArticleIdList></Reference><Reference><Citation>Otwinowski Z, Minor W. Processing of X-ray diffraction data collected in oscillation mode. Macromol Crystallogr Pt A. 1997;276:307&#x2013;326. doi: 10.1016/S0076-6879(97)76066-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0076-6879(97)76066-X</ArticleId><ArticleId IdType="pubmed">27754618</ArticleId></ArticleIdList></Reference><Reference><Citation>Palmenberg AC. Proteolytic processing of picornaviral polyprotein. Annu Rev Microbiol. 1990;44:603&#x2013;623. doi: 10.1146/annurev.mi.44.100190.003131.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.mi.44.100190.003131</ArticleId><ArticleId IdType="pubmed">2252396</ArticleId></ArticleIdList></Reference><Reference><Citation>Palmenberg AC, Rathe JA, Liggett SB. Analysis of the complete genome sequences of human rhinovirus. J Allergy Clin Immunol. 2010;125:1190&#x2013;1199. doi: 10.1016/j.jaci.2010.04.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2010.04.010</ArticleId><ArticleId IdType="pmc">PMC2893015</ArticleId><ArticleId IdType="pubmed">20471068</ArticleId></ArticleIdList></Reference><Reference><Citation>Patick AK, Binford SL, Brothers MA, Jackson RL, Ford CE, Diem MD, Maldonado F, Dragovich PS, Zhou R, Prins TJ, Fuhrman SA, Meador JW, Zalman LS, Matthews DA, Worland ST. In vitro antiviral activity of AG7088, a potent inhibitor of human rhinovirus 3C protease. Antimicrob Agents Chemother. 1999;43:2444&#x2013;2450. doi: 10.1128/AAC.43.10.2444.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/AAC.43.10.2444</ArticleId><ArticleId IdType="pmc">PMC89498</ArticleId><ArticleId IdType="pubmed">10508022</ArticleId></ArticleIdList></Reference><Reference><Citation>Porter AG. Picornavirus nonstructural proteins&#x2014;emerging roles in virus-replication and inhibition of host-cell functions. J Virol. 1993;67:6917&#x2013;6921. doi: 10.1128/JVI.67.12.6917-6921.1993.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.67.12.6917-6921.1993</ArticleId><ArticleId IdType="pmc">PMC238148</ArticleId><ArticleId IdType="pubmed">8230412</ArticleId></ArticleIdList></Reference><Reference><Citation>Robert X, Gouet P. Deciphering key features in protein structures with the new ENDscript server. Nucleic Acids Res. 2014;42:W320&#x2013;324. doi: 10.1093/nar/gku316.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gku316</ArticleId><ArticleId IdType="pmc">PMC4086106</ArticleId><ArticleId IdType="pubmed">24753421</ArticleId></ArticleIdList></Reference><Reference><Citation>Tam JCH, Bidgood SR, McEwan WA, James LC. Intracellular sensing of complement C3 activates cell autonomous immunity. Science. 2014;345:1134. doi: 10.1126/science.1256070.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1256070</ArticleId><ArticleId IdType="pmc">PMC4172439</ArticleId><ArticleId IdType="pubmed">25190799</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsai MT, Cheng YH, Liu YN, Liao NC, Lu WW, Kung SH. Real-time monitoring of human enterovirus (HEV)-infected cells and anti-HEV 3C protease potency by fluorescence resonance energy transfer. Antimicrob Agents Chemother. 2009;53:748&#x2013;755. doi: 10.1128/AAC.00841-08.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/AAC.00841-08</ArticleId><ArticleId IdType="pmc">PMC2630644</ArticleId><ArticleId IdType="pubmed">19015331</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang QM, Chen SH. Human rhinovirus 3C protease as a potential target for the development of antiviral agents. Curr Protein Pept Sci. 2007;8:19&#x2013;27. doi: 10.2174/138920307779941523.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/138920307779941523</ArticleId><ArticleId IdType="pubmed">17305557</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang HT, Yang MJ, Ding Y, Liu YW, Lou ZY, Zhou Z, Sun L, Mo LJ, Ye S, Pang H, Gao GF, Anand K, Bartlam M, Hilgenfeld R, Rao ZH. The crystal structures of severe acute respiratory syndrome virus main protease and its complex with an inhibitor. Proc Natl Acad Sci USA. 2003;100:13190&#x2013;13195. doi: 10.1073/pnas.1835675100.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1835675100</ArticleId><ArticleId IdType="pmc">PMC263746</ArticleId><ArticleId IdType="pubmed">14585926</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>